We
asked c-suite executives throughout the CRO arena to provide their insights on
what the biggest opportunities and barriers for innovation are for improving
the drug development process, as well as identify a recent innovation that is
improving the process.
Insights
from John Potthoff Ph.D., President and CEO, Theorem Clinical Research.
Opportunities:
Clinical trials today generate vast quantities of data that must be understood
before they can be acted upon. The greatest opportunity for innovation in
clinical development of biopharmaceuticals and medical devices lies in advanced
software tools and techniques that allow real-time visualization of information
in ways that speed understanding. In an era of risk-based monitoring and continual
fine-tuning of trial design, connecting data streams with data visualization
techniques provides a way for scientists to “see” multiple levels of data as
they are generated, revealing new insights that can lead to better choices and
decisions. As more and more data sources become available, this ability to
visualize data will lead to an even deeper understanding of patients, products,
and processes.
Posts
